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Value of the data {#sec0001}
=================

•Charge variant mass spectrometry (CV-MS) was utilized to successfully separate the correctly paired and light chain-scrambled mispaired isobaric species which may occur during bispecific antibody production in single host cells.•Scientific researchers in a variety of settings can utilize CV-MS to separate proteoforms based on only minor charge differences and directly analyze by mass spectrometry.•By charge separation of correctly paired and mispaired species, downstream purification of BsIgGs are made possible as an alternative to the incorporation of chain pairing strategies.•Molecular modeling revealed that minor surface exposed charge patches created microenvironments which were sufficient to resolve species, but not significant enough to alter the molecular isoelectric point.

1. Data {#sec0002}
=======

Our data demonstrates an integrated native ion exchange chromatography mass spectrometry based analytical method, CV-MS [@bib0001],[@bib0002], to successfully separate correctly paired and mispaired IgG species which may arise during bispecific antibody production in single host cells [@bib0001].

Anti-HER2/CD3 BsIgG was analyzed by reversed phase HPLC using an organic solvent gradient ([Fig. 1](#fig0001){ref-type="fig"}) and traditional ion exchange using a salt gradient ([Fig. 2](#fig0002){ref-type="fig"}(a)). We were not able to resolve isobaric species with extensive method optimization. A commercially available pH buffer system (CX-1) was also used to confirm the separation of IgG species with pH gradient cation chromatography ([Fig. 2](#fig0002){ref-type="fig"}(b)), but these buffers are incompatible with downstream mass spectral analysis. Charge variant-mass spectrometry (CV-MS) was the only method demonstrated to resolve BsIg scrambled species, and holds the additional benefit of mass spectral detection for species identification [@bib0001]. To demonstrate the separation of impurities in a variety of paired single cell half antibody IgG assemblies by CV-MS, anti-IL-13/IL-4 and anti-EGFR/MET were also analyzed after optimizing the pH gradient for each BsIgG ([Fig. 3](#fig0003){ref-type="fig"}) and show complete separation of the main peak from the BsIg scramble.Fig. 1RPLC-MS analysis of anti-HER2/CD3 BsIgG on HALO RP column showed minor separation of IgG species. (a) UV absorption chromatogram (280 nm) (b) Deconvoluted mass spectrum. Theoretical masses are denoted in parentheses.Fig 1Fig. 2Ion exchange comparison of salt (a) and pH (b) gradients for separating anti-HER2/CD3 BsIgG.Fig 2Fig. 3Native CV-MS analysis of anti-IL-13/IL-4 and anti-EGFR/MET with improved peak separation after pH gradient optimization. UV absorption chromatogram for (a) anti-IL-13/IL-4 and (b) anti-EGFR/MET.Fig 3

To confirm the identity of isobaric species in the single cell anti-HER2/CD3 BsIg, each peak was fraction collected after charge separation. The isoelectric point was compared for each IgG species by iCIEF using iCE3 ([Fig. 4](#fig0004){ref-type="fig"}). The hydrodynamic radius was also compared for each IgG species by SEC-MALS ([Fig. 5](#fig0005){ref-type="fig"}). Lastly, molecular modeling with BioLuminate was used to generate protein titration curves of charge over pH for anti-HER2/CD3 in the research article [@bib0001], as well as two other molecules, anti-IL-13/IL-4 and anti-EGFR/MET ([Fig. 6](#fig0006){ref-type="fig"}, [Fig. 7](#fig0007){ref-type="fig"}). Molecular modeling was employed to localize charge changes for each IgG species over a pH range from 7 to 9 and the surface exposed charge patches were compared ([Fig. 8](#fig0008){ref-type="fig"}, [Fig. 9](#fig0009){ref-type="fig"}).Fig. 4Isoelectric point determination of anti-HER2/CD3 peaks post-fractionation by iCE3 (a) or iCIEF (b).Fig 4Fig. 5Hydrodynamic radius determination of anti-HER2/CD3 peaks post-fractionation.Fig 5Fig. 6Model charge over the indicated pH gradient for anti-IL-13/anti-IL-4 Fv and BsIgG species. (a) Fv domains only (1 = anti-IL-13, 2 = anti-IL-4). (b) Full BsIgG models.Fig 6Fig. 7Model charge over the indicated pH gradient for anti-EGFR/anti-MET. (a) Fv domains only (1 = anti-EGFR, 2 = anti-MET). (b) Full BsIgG models.Fig 7Fig. 8Localized charge changes in anti-IL-13/IL-4 BsIgG species over a pH range from 7 to 9. (a) Models of the bispecific that is either correctly paired or mispaired. Anti-IL-4 is shown in red (heavy chain) and wheat (light chain), anti-IL-13 is dark blue (heavy chain) and light blue (light chain). (b) Views of the correctly paired anti-IL-13/IL-4. For orientation the same views are used in (c--e). (c and d) Surface view of charge changes at pH 9 subtracted from pH 7 for each residue over pH gradient for (c) H1L1/H2L2 or (d) H1L2/H2L1. (e) Identical residue positions of maps (c) and (d) are subtracted for mapping onto the H1L1/H2L2 model. Areas of color change indicate regions with the largest difference charge change over the pH gradient between H1L1/H2L2 and H1L2/H2L1.Fig 8Fig. 9Localized charge changes in anti-EGFR/MET BsIgG species over a pH range from 7 to 9. (a) Correctly paired or mispaired anti-EGFR/MET BsIgGs. Anti-MET chains are red (heavy) and wheat (light), anti-EGFR chains are shown in dark blue (heavy) and light blue (light). (b) Correctly paired anti-EGFR/MET. (c and d) Surface view of charge changes at pH 9 subtracted from pH 7 for each residue over pH gradient for (c) H1L1/H2L2 or (d) H1L2/H2L1. (e) Subtraction between the maps in (c) and maps in (d) mapped onto the H1L1/H2L2 model.Fig 9

2. Experimental design, materials, and methods {#sec0003}
==============================================

Below is a brief description of the experimental methods used to acquire data in this paper. For a more detailed and thorough report, please refer to the related research article [@bib0001].

2.1. Native CV-MS {#sec0004}
-----------------

Bispecific antibodies were buffer exchanged into 50 mM ammonium acetate and separated on a ProPac WCX-10 column (Thermo Scientific) using gradients optimized for each individual BsIgG. The HPLC was coupled to a Thermo Exactive Plus EMR Orbitrap (Thermo Fisher Scientific). Acquired data was processed with Thermo Xcalibur Qual Brower and Thermo Protein Deconvolution 4.0.

2.2. Offline reversed phase separation and ion exchange {#sec0005}
-------------------------------------------------------

Separation of anti-HER2/CD3 BsIgG was evaluated on a HALO RP column and analyzed on a Thermo Exactive Plus EMR Orbitrap instrument for native CV-MS comparison. Anti-HER2/CD3 BsIgG was also buffer exchanged into 50 mM ammonium acetate, pH 7 and separated offline using a ProPac WCX-10 column on a Shimadzu FRC-10A instrument. Traditional IEC salt gradient and commercial pH gradient (CX-1 pH Gradient Buffer Kit, Thermo Scientific), which are incompatible with downstream mass spectral analysis, were used for offline separation and compared to native CV-MS.

2.3. Comparison of anti-HER2/CD3 bispecific and mispaired IgGs by iCIEF and SEC-MALS {#sec0006}
------------------------------------------------------------------------------------

Buffer exchanged anti-HER2/CD3 BsIgG was separated and fractionated offline using a ProPac WCX-10 column on a Shimadzu FRC-10A instrument. Fractionated anti-HER2/CD3 bispecific and mispaired IgGs were analyzed by iCIEF using iCE3 to determine differences in isoelectric point. Fractionated samples were also analyzed by SEC-MALS using quasi elastic light scattering (QELS) to determine differences in hydrodynamic radius. The Stokes-Einstein relationship was used to calculate R~H~ from measured diffusion coefficients.

2.4. Molecular modeling {#sec0007}
-----------------------

Initial Fv models with correctly paired chains were built using the commands described in the main research article.

Templates used for the respective Fv models are given in the table below.ModelHC Fv templateLC Fv templateFramework templateHC loop templatesLC loop templates4D5_Fv6BAH_B5EU7_C1N8Z_AH1: 3MLT\
H2: 5UEA\
H3: 1N8ZL1: 5TD0\
L2: 1DQQ\
L3: 5TDPCD3_Fv3EO9_H2WUC_L3EO9_LH1: 6AQ7\
H2: 5VF2\
H3: 4EDXL1: 5U4R\
L2: 3CMO\
L3: 1GHF4D5HC_CD3LC_Fv6BAH_B2WUC_L3BDY_LH1: 3MLT\
H2: 5UEA\
H3: 1N8ZL1: 5U4R\
L2: 3CMO\
L3: 1GHFCD3HC_4D5LC_Fv3EO9_H5EU7_C3EO9_LH1: 6AQ7\
H2: 5VF2\
H3: 4EDXL1: 5TD0\
L2: 1DQQ\
L3: 5TDPIL13_Fv4I77_H3INU_L4I77_LH1: 1FN4\
H2: 2HWZ\
H3: 5EZJL1: 4I77\
L2: 5EOC\
L3: 4HS6IL4_Fv5EU7_E2WUC_L4G7V_LH1: 3BPC\
H2: 4LRI\
H3: 1IGTL1: 5TKK\
L2: 2Q8B\
L3: 4LVEIL13HC_IL4LC_Fv4I77_H2WUC_L6APB_LH1: 4I77\
H2: 2HWZ\
H3: 4I77L1: 5TKK\
L2: 2Q8B\
L3: 4LVEIL4HC_IL13LC_Fv5EU7_E3INU_L3INU_LH1: 3BPC\
H2: 4LRI\
H3: 1IGTL1: 4I77\
L2: 5EOC\
L3: 4HS6EGFR_Fv3P0V_H2WUC_L3P0V_LH1: 3FB5\
H2: 3N9G\
H3: 4NYLL1: 3SOB\
L2: 2R8S\
L3: 6APBMET_Fv4K3J_H2WUC_L4K3J_LH1: 1NGZ\
H2: 2XQY\
H3: 4G7VL1: 4K3J\
L2: 5IFA\
L3: 1ZA6EGFRHC_METLC_Fv3P0V_H2WUC_L3P0V_LH1: 3FB5\
H2: 3N9G\
H3: 4NYLL1: 4K3J\
L2: 5IFA\
L3: 4LVEMETHC_EGFRLC_Fv4K3J_H2WUC_L4K3J_LH1: 1NGZ\
H2: 2XQY\
H3: 4G7VL1: 3SOB\
L2: 2R8S\
L3: 6APB

Charge and pKa of the individual residues were calculated using the BioLuminate Protein Titration Curve tool (Schrödinger, Suites 2018-4) in 0.1 increments over a range of pH 6--10.

Models of the correctly paired and light chain-scrambled species were aligned in BioLuminate and renumbered. Alignment and numbering were checked and renumbered manually if required.

Difference in charge between pH 9 and pH 7 was calculated, as were the differences in change of charge per residue as described in the reference article.
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